138 related articles for article (PubMed ID: 25352450)
1. Serum leptin is not altered nor related to cognitive decline in Alzheimer's disease.
Teunissen CE; van der Flier WM; Scheltens P; Duits A; Wijnstok N; Nijpels G; Dekker JM; Blankenstein RM; Heijboer AC
J Alzheimers Dis; 2015; 44(3):809-13. PubMed ID: 25352450
[TBL] [Abstract][Full Text] [Related]
2. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
[TBL] [Abstract][Full Text] [Related]
3. Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study.
Laske C; Sopova K; Hoffmann N; Stransky E; Hagen K; Fallgatter AJ; Stellos K; Leyhe T
J Alzheimers Dis; 2011; 26(1):39-45. PubMed ID: 21593573
[TBL] [Abstract][Full Text] [Related]
4. Plasma leptin levels and free leptin index in women with Alzheimer's disease.
Baranowska-Bik A; Bik W; Styczynska M; Chodakowska-Zebrowska M; Barcikowska M; Wolinska-Witort E; Kalisz M; Martynska L; Baranowska B
Neuropeptides; 2015 Aug; 52():73-8. PubMed ID: 26070219
[TBL] [Abstract][Full Text] [Related]
5. The influence of vascular risk factors on cognitive decline in patients with Alzheimer's disease.
Blom K; Vaartjes I; Peters SA; Koek HL
Maturitas; 2014 Sep; 79(1):96-9. PubMed ID: 25059438
[TBL] [Abstract][Full Text] [Related]
6. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
[TBL] [Abstract][Full Text] [Related]
7. Relation between uric acid and Alzheimer's disease in elderly Jordanians.
Al-khateeb E; Althaher A; Al-khateeb M; Al-Musawi H; Azzouqah O; Al-Shweiki S; Shafagoj Y
J Alzheimers Dis; 2015; 44(3):859-65. PubMed ID: 25362039
[TBL] [Abstract][Full Text] [Related]
8. [Clinical presentation of Moroccan cases with Alzheimer's disease].
El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure variability in Alzheimer's disease and frontotemporal dementia: the effect on the rate of cognitive decline.
Lattanzi S; Luzzi S; Provinciali L; Silvestrini M
J Alzheimers Dis; 2015; 45(2):387-94. PubMed ID: 25790932
[TBL] [Abstract][Full Text] [Related]
10. Plasma fetuin-A is associated with the severity of cognitive impairment in mild-to-moderate Alzheimer's disease.
Smith ER; Nilforooshan R; Weaving G; Tabet N
J Alzheimers Dis; 2011; 24(2):327-33. PubMed ID: 21239851
[TBL] [Abstract][Full Text] [Related]
11. Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.
Rodriguez MJ; Potter E; Shen Q; Barker W; Greig-Custo M; Agron J; Loewenstein D; Duara R
Alzheimers Dement; 2012 May; 8(3):211-8. PubMed ID: 22546353
[TBL] [Abstract][Full Text] [Related]
12. Association between Peripheral Leptin and Adiponectin Levels and Cognitive Decline in Patients with Neurocognitive Disorders ≥65 Years.
Gilbert T; Roche S; Blond E; Bar JY; Drai J; Cuerq C; Haution-Bitker M; Ecochard R; Bonnefoy M
J Alzheimers Dis; 2018; 66(3):1255-1264. PubMed ID: 30400097
[TBL] [Abstract][Full Text] [Related]
13. Corpus callosum atrophy and cognitive decline in early Alzheimer's disease: longitudinal MRI study.
Zhu M; Wang X; Gao W; Shi C; Ge H; Shen H; Lin Z
Dement Geriatr Cogn Disord; 2014; 37(3-4):214-22. PubMed ID: 24193144
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and cognitive impact of cerebrovascular findings in Alzheimer's disease: a retrospective, naturalistic study.
Tabet N; Quinn R; Klugman A
Int J Clin Pract; 2009 Feb; 63(2):338-45. PubMed ID: 19196375
[TBL] [Abstract][Full Text] [Related]
15. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.
Squitti R; Bressi F; Pasqualetti P; Bonomini C; Ghidoni R; Binetti G; Cassetta E; Moffa F; Ventriglia M; Vernieri F; Rossini PM
Neurology; 2009 Jan; 72(1):50-5. PubMed ID: 19122030
[TBL] [Abstract][Full Text] [Related]
18. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
[TBL] [Abstract][Full Text] [Related]
19. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.
Kim TS; Lim HK; Lee JY; Kim DJ; Park S; Lee C; Lee CU
Neurosci Lett; 2008 May; 436(2):196-200. PubMed ID: 18378084
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin and leptin secretion in patients with moderate Alzheimer's disease.
Theodoropoulou A; Metallinos IC; Psyrogiannis A; Vagenakis GA; Kyriazopoulou V
J Nutr Health Aging; 2012 May; 16(5):472-7. PubMed ID: 22555794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
